Use code BLACKFRIDAY
for 40% off your first month (limited time only)
faber ∞ protocol
Peptides · The basics

What is a peptide?

The short answer

  • A short chain of amino acids, usually 50 or fewer. Longer chains are proteins.
  • Your body runs on them. Insulin and GLP-1 are peptides.
  • Most peptide drugs are injected, because digestion breaks them down.
  • The evidence ranges from approved medicines to peptides with limited human data.

Written by Fabian Fuchs, Founder · Published November 14, 2026 · 8 min read

BPC-157 vial

What is a peptide, exactly?

A peptide is a short chain of amino acids, the same building blocks that make up proteins. The usual line is about 50: up to that, it is a peptide, anything longer is a protein.3

Size is the point. A peptide is small enough to travel as a precise messenger and specific enough to carry one clear instruction to one type of cell.

Your body makes hundreds of them. Insulin, which controls blood sugar, is a peptide hormone. So is GLP-1, the gut hormone that tells your brain you are full. "Peptide therapy" usually means one thing: take a signal your body already uses, or a close copy of it, and give it in a set dose.

Peptides are short chainsAmino acids per molecule. Up to about 50 it is a peptide; longer chains are proteins.
KPV
3
Epitalon
4
Tirzepatide
39
Insulin
51
Sources: Wang 2022; FDA tirzepatide label 2022. KPV and epitalon by sequence.

How long have peptides been used as medicine?

About a century. Insulin was first isolated in 1921 and became the first commercial peptide drug in 1923.1 Most peptide medicine since has followed the same idea: find a signal the body is short on, then supply it.

Today more than 80 peptide drugs are approved worldwide, and more than 170 are in clinical development.1 The FDA approved 34 between 2016 and 2024.2 The best known are recent: semaglutide in 2017 and tirzepatide in 2022.5, 6

How do peptide drugs work?

Most pills are small molecules: compact chemicals that slip into cells and block or nudge part of the machinery. Peptides work from the outside. Each one fits a specific receptor on the cell surface, like a key in a lock, the same way your own hormones do.

That gives them two traits. They are precise, binding their target and little else. And they act on pathways your body already runs.

Semaglutide shows the engineering involved. Your own GLP-1 lasts about two minutes in the blood before enzymes break it down.4 Semaglutide is almost identical to it, with a few deliberate changes that let it ride on albumin, a blood protein. Its half-life is about a week, which is why one injection a week is enough.5

Why are most peptides injected?

Your gut treats them as food. Stomach acid and enzymes cut them into single amino acids before they reach your blood. For most peptides taken by mouth, less than 1% of the dose gets through. Even the one oral semaglutide tablet delivers only about 1%.7

So most peptides come as a small injection under the skin, a nasal spray or a cream, depending on the molecule.

Is every peptide backed by the same evidence?

No. "Peptide" covers everything from insulin to molecules that have barely been tested in people. It helps to sort them into four tiers.

1

FDA-approved peptide medicines

Insulin, semaglutide and tirzepatide have passed full FDA review for specific uses. A compounded version is different: a licensed pharmacy prepares it for one patient's prescription. It is not FDA-approved and is not the same as any brand-name medicine.

2

Once approved, now compounded

Sermorelin was approved by the FDA in the 1990s for growth hormone deficiency in children. Its maker stopped selling it in 2008. In 2013 the FDA determined it was not withdrawn for safety or effectiveness reasons.8 Today licensed pharmacies compound it with a prescription.

3

Skin and cosmetic evidence

GHK-Cu is a copper peptide first found in human plasma in 1973. Levels fall with age. Most of its research is on skin, in lab and cosmetic studies.9 It has no FDA drug approval.

4

Newer peptides with limited human data

BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon sit here. None is an FDA-approved drug. Human data is limited, and for several of them the work so far is in the lab and in animals.15, 16 In 2026 they became the subject of a new HHS policy.

What changed for peptides in 2026?

2023FDA lists them as a safety concern for compounding
April 2026They come off that list
July 2026An FDA advisory committee recommends six
Oct 28, 2026HHS announces an interim policy

The policy was published in the Federal Register on October 30.11 In plain words, HHS says it does not intend to act against licensed pharmacies and prescribers that compound six peptides, as long as every condition is met.10, 14 The main conditions include:

What it is not:

PeptideStudied forRoute HHS coversHuman evidence
BPC-157BPC-157Gut and tendon healing, mostly in animalsInjection, by mouth, on the skinLimited
TB-500TB-500Wound and tissue repairInjectionLab and animal studies only
KPVKPVGut and skin inflammationOn the skin, by mouthLab and animal studies only
MOTS-cMOTS-cMetabolism and energy useInjectionLab and animal studies only
SemaxSemaxRecovery after stroke, focusNasal sprayLimited
EpitalonEpitalonSleep rhythm and agingInjection, in cyclesLimited

Injection means under the skin or into muscle. Routes from HHS Appendix B.10 Evidence from FDA's 2026 review and published summaries.15, 16

Are peptides safe?

"Natural" or "something your body already makes" does not mean harmless. Peptides are potent signals, dosed in fractions of a milligram. Approved peptide drugs have real, documented side effects. With GLP-1 medicines, nausea is the most common.5

For the six newer peptides, long-term safety in people is not yet known, because the large human studies have not been done.

Quality is the other variable. The HHS conditions exist for that reason: a known manufacturer and a tested ingredient.

Treat any therapeutic peptide like a prescription medicine. A clinician reviews your health first, a licensed pharmacy prepares it, and you get written dosing instructions.

What this means for you

Start from your goal, not the molecule.

Gain muscleSermorelin
Repair bodyBPC-157, TB-500, Epitalon, KPV (coming soon)
Boost longevityMOTS-c, Semax (coming soon)
Renew skinGHK-Cu

For the newer peptides, go in with clear expectations: the human data is limited, and a clinician decides whether one fits you. Every faber protocol membership starts with a clinician review of your health history, and you are charged only if prescribed.

Quick answers.

Are peptides steroids?

No. Anabolic steroids are synthetic versions of testosterone, a different class of molecule. Some peptides act on hormone systems. Sermorelin, for example, prompts your pituitary to release growth hormone. But they are not steroids.

Do peptides need a prescription?

Therapeutic peptides do in the U.S., including creams a pharmacy compounds. Peptides in store-bought skincare do not.

How are peptides taken?

Most often as a small injection under the skin, because digestion breaks them down. Some come as nasal sprays or creams, and a few by mouth.

What is the difference between a peptide and a protein?

Length. Both are chains of amino acids. Below about 50, the chain is called a peptide; above that, a protein.

Are peptides legal in the U.S.?

Approved peptide drugs are, with a prescription. For six others, HHS said in October 2026, in a draft interim policy, that it would not act against licensed pharmacies that compound them under strict conditions. That is enforcement discretion, not approval, and states can set stricter rules.

Is BPC-157 FDA-approved?

No. The 2026 HHS policy covers compounded BPC-157 as an injection, by mouth or on the skin. It has no FDA approval and limited human data.

Sources (16)
  1. Wang L, Wang N, Zhang W, et al. "Therapeutic peptides: current applications and future directions." Signal Transduction and Targeted Therapy, 2022. nature.com/articles/s41392-022-00904-4
  2. AlShaer D, Al Musaimi O, Albericio F, de la Torre BG. "2025 FDA TIDES (Peptides and Oligonucleotides) Harvest." Pharmaceuticals, 2026. mdpi.com/1424-8247/19/2/244
  3. Forbes Kaprive J, Krishnamurthy K. "Biochemistry, Peptide." StatPearls, NIH National Library of Medicine, updated 2023. ncbi.nlm.nih.gov/books/NBK562260
  4. Holst JJ. "From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy." Frontiers in Endocrinology, 2019. frontiersin.org/...fendo.2019.00260
  5. FDA. Semaglutide injection prescribing information, 2017. accessdata.fda.gov/...209637lbl.pdf
  6. FDA. Tirzepatide injection prescribing information, 2022. accessdata.fda.gov/...215866s000lbl.pdf
  7. Baral KC, Choi KY. "Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances." Pharmaceutics, 2025. mdpi.com/1999-4923/17/4/397
  8. FDA. "Determination That GEREF (Sermorelin Acetate) Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness." Federal Register, March 4, 2013. govinfo.gov/...2013-04827
  9. Pickart L, Margolina A. "Skin Regenerative and Anti-Cancer Actions of Copper Peptides." Cosmetics, 2018. mdpi.com/2079-9284/5/2/29
  10. HHS. "Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances," Appendix B, 2026. hhs.gov/...appendix-b.pdf
  11. Federal Register. Notice 2026-22192, October 30, 2026. federalregister.gov/...2026-22192
  12. Venable LLP. "HHS Announces Interim Enforcement Discretion for Section 503A Compounding with Certain Peptide Bulk Drug Substances," November 2026. venable.com/insights/...
  13. Arnold & Porter. "HHS Announces Draft Enforcement Discretion Policy Paving Way for Pharmacies," November 2026. arnoldporter.com/...
  14. Holland & Knight. "HHS Issues Interim Enforcement Discretion Policy for Compounding of 6 Peptides," November 4, 2026. hklaw.com/insights/...
  15. FDA. Briefing document, Pharmacy Compounding Advisory Committee, July 23 to 24, 2026: Semax-related bulk drug substances. fda.gov/media/193348
  16. Health Affairs Forefront. "FDA Advisory Committee's Vote May Open a Drug-Compounding Back Door for Unapproved Peptides," August 2026. healthaffairs.org/...

This article is educational and is not medical advice, diagnosis or a treatment recommendation. Study findings describe group averages and do not predict your result. Regulatory status can change; this page reflects the rules as of its update date. Prescription decisions at faber protocol are made by U.S. state-licensed clinicians after a review of your health history and, where indicated, laboratory testing.

The medicine is one part.
The protocol is the rest.

Every prescription comes with a plan for the habits around it.

Get started →